Literature DB >> 8188883

Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases.

M S Daoud1, W P Su, K M Leiferman, C Perniciaro.   

Abstract

BACKGROUND: Bullous morphea is a rare disease. Its pathogenesis is unknown.
OBJECTIVE: We evaluated bullous morphea clinically, pathologically, and immunopathologically and investigated the role of spirochetes and eosinophils in its pathogenesis.
METHODS: The clinical and pathologic findings from 13 patients with bullous morphea were reviewed. Tissue sections were studied with the Elias-Bosma stain for spirochetes and indirect immunofluorescence for eosinophil granule major basic protein.
RESULTS: Bullae were found in all forms of morphea; the lower extremities were the most common sites of involvement. Lymphatic dilatation was found in 77% of the patients. Deposition of major basic protein was found in 60% of cases studied. There was no evidence of spirochetes in any of the specimens examined with the Elias-Bosma stain.
CONCLUSION: Our results suggest that the pathogenesis of bullous morphea is related to lymphatic dilatation as well as release of major basic protein from eosinophils in some patients. We found no association between spirochetes and bullous morphea.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188883     DOI: 10.1016/s0190-9622(94)70113-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  [Generalized circumscribed scleroderma with blisters].

Authors:  G Wagner; V Meyer; M M Sachse
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

Review 2.  Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.

Authors:  J R Goodlad; M M Davidson; P Gordon; R Billington; D O Ho-Yen
Journal:  Mol Pathol       Date:  2002-12

3.  Lymphatic Obstruction as a Rare Complication of Morphea and Response to Intralesional Steroid.

Authors:  Ishmeet Kaur; Archana Singal; Deepak Jakhar; Deepika Pandhi
Journal:  J Cutan Aesthet Surg       Date:  2019 Jan-Mar

4.  A case of lichen sclerosus et atrophicus accompanying bullous morphea.

Authors:  Sirin Yasar; Ceyda Tanzer Mumcuoglu; Zehra Asiran Serdar; Pembegul Gunes
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

Review 5.  Progressive hemifacial atrophy: a review.

Authors:  Stanislav N Tolkachjov; Nirav G Patel; Megha M Tollefson
Journal:  Orphanet J Rare Dis       Date:  2015-04-01       Impact factor: 4.123

Review 6.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

7.  Frequency of Borrelia in Morphea Lesion by Polymerase Chain Reaction in Northeast of Iran.

Authors:  Mohhamad Javad Yazdanpanah; Norieh Sharifi; Alireza Khooei; Mahnaz Banihashemi; Mohammad Khaje-Daluee; Azadeh Shamsi; Kiarash Ghazvini
Journal:  Jundishapur J Microbiol       Date:  2015-08-27       Impact factor: 0.747

Review 8.  Update on Management of Morphea (Localized Scleroderma) in Children.

Authors:  Renu George; Anju George; T Sathish Kumar
Journal:  Indian Dermatol Online J       Date:  2020-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.